Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yangzhou Pharmaceutical Co., Ltd., a subsidiary of Sinopharm (China National Pharmaceutical Group), is a comprehensive pharmaceutical manufacturer based in Yangzhou, China. The company specializes in the production of active pharmaceutical ingredients (APIs) and finished dosage forms, with a strong historical focus on steroid hormones and anti-inflammatory agents. Its product portfolio includes a wide range of glucocorticoids, antibiotics, and analgesics distributed both domestically and internationally. Yangzhou Pharmaceutical operates large-scale manufacturing facilities that comply with GMP standards, serving as a key production base for the Sinopharm Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangzhou Pharmaceutical.